Probiotic and blueberry extract for immune aging in people with HIV who drink alcohol
Tests Limosilactobacillus reuteri and blueberry extract in people with HIV who drink alcohol.
Plain-language title generated from the registry record
Registry title: Precision Microbiota Interventions for Senoreduction Trial
Key facts
- Where
- New Orleans, United StatesSee the site
- Phase
- Phase 1/2
Where in United States
- LSU HealthNew Orleans, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Louisiana State University Health Sciences Center in New Orleans
- Trial code
- NCT07462767
- Record updated
- 29 October 2026
- Original description
People with HIV who drink alcohol are at increased risk for accelerated aging biology, including increased immune senescence. This randomized, double-blind, crossover clinical trial evaluates two generally recognized as safe (GRAS) microbiota-targeted interventions on immune senescence biomarkers.Read full original descriptionShow less
Geroprotective Precision Medicine Strategies in PWH That Use Alcohol
People with HIV who drink alcohol are at increased risk for accelerated aging biology, including increased immune senescence. This randomized, double-blind, crossover clinical trial evaluates two generally recognized as safe (GRAS) microbiota-targeted interventions on immune senescence biomarkers.
Inclusion: Age ≥40 years; People with HIV; Recent alcohol use defined as ≥42 grams in the prior week and positive urine ethyl glucuronide (EtG).
Exclusion: Allergy to study products; Probiotic use in past 3 months; Recent antibiotics or immunosuppressives; Pregnancy or breastfeeding; Inability to comply.